SCHEMBL8307019

SCHEMBL8307019

CC(=NO)c1ccc(S(=O)(=O)c2ccccc2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.48
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
POLB P06746 1/20 0.40
KDM4E B2RXH2 2/20 0.39
AKR1B1 P15121 1/20 0.39
NAMPT P43490 1/20 0.38
KMT2A Q03164 2/20 0.38
P4HTM Q9NXG6 2/20 0.38
GFER P55789 2/20 0.38
HSP90AA1 P07900 1/20 0.38
CXCR5 P32302 1/20 0.38
APLNR P35414 1/20 0.38
RAB9A P51151 1/20 0.38
CCR6 P51684 1/20 0.38
HTR6 P50406 1/20 0.37
CA9 Q16790 1/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27347914 0.83 AGTR1 (0.51) AGTR1CYP11B1CYP11B2KDM4EAKR1B1
SCHEMBL8688680 0.80 AGTR1 (0.41) AGTR1CYP11B1CYP11B2POLBKDM4E
SCHEMBL8305647 0.79 AGTR1 (0.40) AGTR1CYP11B1CYP11B2NAMPTHTR6
SCHEMBL8305650 0.79 AGTR1 (0.40) AGTR1CYP11B1CYP11B2NAMPTHTR6
SCHEMBL8304940 0.79 HTR6 (0.52) POLBKDM4ENAMPTKMT2AGFER
SCHEMBL6943431 0.73 CYP11B1 (0.57) AGTR1CYP11B1CYP11B2KDM4EAKR1B1
SCHEMBL10834173 0.72 AGTR1 (0.65) AGTR1CYP11B1CYP11B2KDM4EAKR1B1
SCHEMBL8308362 0.70 LDHA (0.59) KDM4EP4HTMGFERRAB9ACA9
SCHEMBL3377180 0.69 PKM (0.59) AGTR1CYP11B1CYP11B2POLBKDM4E
SCHEMBL4653156 0.69 AGTR1 (0.57) AGTR1CYP11B1CYP11B2KDM4EAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed